Skip to content
OpenCapital
Get started
McKesson logo

McKesson

MCK

McKesson Corporation is a leading global healthcare services company that provides pharmaceutical distribution, medical-surgical supply logistics, and healthcare technology solutions.

Market cap
$95.85B+6.7%
Revenue$403.43B+12.4%
Net income$4.8B+44.5%
Free cash flow$5.7B+3.1%
EPS (diluted)$38.41+49.2%
Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q4 2026 report

May 7, 2026
Revenue$96.3BMiss by $5.1BEPS$11.69Beat by $0.13

Next report

Aug 5, 2026 (In 3 weeks)
Revenue estimate$103.80B
EPS estimate$9.59

Financials

Q4 2026

Income statement

See full
Revenue$96.3B+6.0%
Gross profit$4.0B+11.1%
Operating income$2.2B+35.1%
Net income$1.7B+33.5%
EPS (diluted)$13.65+37.6%

Balance sheet

See full
Cash & equivalents$4.0B-33.3%
Total debt$2.3B-74.2%
Total equity-$2.2B-4.7%
Total assets$82.3B+9.6%

Cash flow

See full
Operating cash flow$3.4B-55.8%
CapEx$111.0M-34.3%
Free cash flow$3.3B-56.3%

Valuation & ratios

Valuation

See full
Market cap$95.85B+6.7%
Enterprise value$94.15B-4.3%
P/E20.1×-8.3×
P/S0.2×0.0×

Profitability

See full
Gross margin3.6%-0.1pp
Operating margin1.5%+0.3pp
Net margin1.2%+0.3pp
FCF margin1.4%-0.1pp

Returns & leverage

See full
Current ratio0.9×0.0×

Segments

By segment

See full
North American Pharmaceutical$79.1B—
Oncology & Multispecialty$12.7B—
Medical-Surgical Solutions$2.9B+0.5%
Prescription Technology Solutions$1.5B—

Competitors

By market cap

McKesson logo
McKesson$95.8B+6.7%
Cencora logo
Cencora$60.2B—
Cardinal Health logo
Cardinal Health$55.5B+41.1%
Becton, Dickinson and Company logo
Becton, Dickinson and Company$41.5B-17.8%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.$13.8B+256%
Doximity logo
Doximity$4.0B-65.8%
Omnicell logo
Omnicell$2.1B+46.8%
GoodRx Holdings, Inc. logo
GoodRx Holdings, Inc.$1.0B-40.4%

By revenue growth

BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.+28.0%
Doximity logo
Doximity+13.1%
Cardinal Health logo
Cardinal Health+12.8%
McKesson logo
McKesson+12.4%
Omnicell logo
Omnicell+7.9%
Becton, Dickinson and Company logo
Becton, Dickinson and Company+6.4%
Cencora logo
Cencora+5.9%
GoodRx Holdings, Inc. logo
GoodRx Holdings, Inc.-1.2%

By net margin

Doximity logo
Doximity30.4%-8.7pp
Becton, Dickinson and Company logo
Becton, Dickinson and Company5.33%-2.1pp
GoodRx Holdings, Inc. logo
GoodRx Holdings, Inc.2.61%-1.0pp
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.2.27%+2.3pp
Omnicell logo
Omnicell1.69%+0.2pp
McKesson logo
McKesson1.18%+0.3pp
Cardinal Health logo
Cardinal Health0.62%-0.1pp
Cencora logo
Cencora0.599%+0.6pp

Profile

McKesson Corporation is a leading global healthcare services company that provides pharmaceutical distribution, medical-surgical supply logistics, and healthcare technology solutions. The company serves as a critical link in the healthcare supply chain, connecting biopharmaceutical manufacturers and medical suppliers with pharmacies, hospitals, and physician practices to improve patient outcomes and operational efficiency.

Competitive position

McKesson is one of the largest pharmaceutical distributors in North America, leveraging massive scale and a diversified portfolio of technology and clinical services to maintain a leading market position.

GeographiesUnited States, Canada, Norway
Customer segmentsPharmacies, Hospitals, Biopharmaceutical manufacturers, Physician practices
Business modelWholesale distribution, B2B services, Franchising, Software-as-a-Service (SaaS)
SuppliersPharmaceutical manufacturers, Medical-surgical equipment manufacturers, Generic drug producers, Biotechnology firms
CustomersRetail pharmacy chains, Independent pharmacies, Hospitals and health systems, Specialty clinics, Government healthcare agencies
CountryUnited States of America
Listed1987
Employees51.0K
CEOBrian S. Tyler
SectorHealthcare
IndustryMedical - Distribution
Websitemckesson.com
FilingsSEC EDGAR

Questions, answered.

What is McKesson's market cap?
McKesson (MCK) has a market capitalization of $95.8B and trades on NYSE.
What is McKesson's revenue and profitability?
McKesson generated $403.43B in trailing twelve-month revenue with net income of $4.8B, representing a net margin of 1.2%. Gross margin stands at 3.6%, with free cash flow of $5.7B. These figures are based on the Q1 2026 filing.
Who are McKesson's competitors?
McKesson's key competitors include Cardinal Health, Inc., Cencora, Inc., BrightSpring Health Services, Inc. Common Stock, and others. These companies compete in similar markets and product categories.
Who does McKesson partner with?
McKesson's notable partners include Walmart Inc., CVS Health Corporation, Centers for Disease Control and Prevention (CDC).
What subsidiaries does McKesson have?
McKesson's subsidiaries include The US Oncology Network, Ontada, SCRI Oncology, LLC, and others.
Where is McKesson headquartered?
McKesson is headquartered in United States of America and employs approximately 51,000 people. It has been publicly traded since 1987.